Synergy between Laminin-Derived Elastin-like Polypeptides (LELPs) Optimizes Cell Spreading
Biomacromolecules · 2024
DOI: 10.1021/acs.biomac.4c00144 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomacromolecules, 2024. Verfasst von Anh T Truong und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Pharmaceutical Sciences, Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, University of Southern Califor…. Hauptthemen laut MEDLINE: Laminin, Elastin, Cell Adhesion. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NEI NIH HHS, NCI NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
A major component of the extracellular matrix (ECM), laminins, modulates cells via diverse receptors. Their fragments have emerging utility as components of "ECM-mimetics" optimized to promote cell-based therapies. Recently, we reported that a bioactive laminin peptide known as A99 enhanced cell binding and spreading via fusion to an elastin-like polypeptide (ELP). The ELP "handle" serves as a rapid, noncovalent strategy to concentrate bioactive peptide mixtures onto a surface. We now report that this strategy can be further generalized across an expanded panel of additional laminin-derived elastin-like polypeptides (LELPs). A99 (AGTFALRGDNPQG), A2G80 (VQLRNGFPYFSY), AG73 (RKRLQVQLSIRT), and EF1m (LQLQEGRLHFMFD) all promote cell spreading while showing morphologically distinct F-actin formation. Equimolar mixtures of A99:A2G80-LELPs have synergistic effects on adhesion and spreading. Finally, three of these ECM-mimetics promote the neurite outgrowth of PC-12 cells. The evidence presented here demonstrates the potential of ELPs to deposit ECM-mimetics with applications in regenerative medicine, cell therapy, and tissue engineering.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Pharmaceutical Sciences, Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, University of Southern California, Los Angeles, California 90089, United States.
- Department of Clinical Biochemistry, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, Hachioji, Tokyo 192-0392, Japan.
- Department of Biomedical Engineering, Viterbi School of Engineering, University of Southern California, Los Angeles, California 90089, United States.
- Department of Drug Safety and Risk Management, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, Hachioji, Tokyo 192-0392, Japan.
- Department of Ophthalmology, Keck School of Medicine, University of Southern California, Los Angeles, California 90033, United States.
ORCID-Profile: Keisuke Hamada, Yuji Yamada, Motoyoshi Nomizu, J Andrew MacKay
Förderung
- NEI NIH HHS
- NCI NIH HHS
- NIGMS NIH HHS
- National Eye Institute
- Japan Society for the Promotion of Science London
Zitieren
APA
Truong, A. T., Lee, S. J., Hamada, K., Kiyomi, A., Guo, H., Yamada, Y., Kikkawa, Y., Okamoto, C. T., Nomizu, M., & MacKay, J. A. (2024). Synergy between Laminin-Derived Elastin-like Polypeptides (LELPs) Optimizes Cell Spreading. Biomacromolecules. https://doi.org/10.1021/acs.biomac.4c00144
Vancouver
Truong AT, Lee SJ, Hamada K, Kiyomi A, Guo H, Yamada Y, et al. Synergy between Laminin-Derived Elastin-like Polypeptides (LELPs) Optimizes Cell Spreading. Biomacromolecules. 2024. doi:10.1021/acs.biomac.4c00144
BibTeX
@article{Truong2024,
author = {Truong, Anh T and Lee, Shin-Jae and Hamada, Keisuke and Kiyomi, Anna and Guo, Hao and Yamada, Yuji and Kikkawa, Yamato and Okamoto, Curtis T and Nomizu, Motoyoshi and MacKay, J Andrew},
title = {Synergy between Laminin-Derived Elastin-like Polypeptides (LELPs) Optimizes Cell Spreading},
journal = {Biomacromolecules},
year = {2024},
doi = {10.1021/acs.biomac.4c00144}
}
EUVIMED